Table of Content

1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Recurrent Glioblastoma Multiforme Treatment Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis

2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact

3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans

5 Analysis of Leading Companies
5.1 Roche
5.1.1 Roche Company Profile
5.1.2 Roche Business Overview
5.1.3 Roche Recurrent Glioblastoma Multiforme Treatment Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Roche Recurrent Glioblastoma Multiforme Treatment Products Introduction
5.2 GlaxoSmithKline
5.2.1 GlaxoSmithKline Company Profile
5.2.2 GlaxoSmithKline Business Overview
5.2.3 GlaxoSmithKline Recurrent Glioblastoma Multiforme Treatment Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 GlaxoSmithKline Recurrent Glioblastoma Multiforme Treatment Products Introduction
5.3 Pfizer Inc
5.3.1 Pfizer Inc Company Profile
5.3.2 Pfizer Inc Business Overview
5.3.3 Pfizer Inc Recurrent Glioblastoma Multiforme Treatment Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Pfizer Inc Recurrent Glioblastoma Multiforme Treatment Products Introduction
5.4 Astrazeneca
5.4.1 Astrazeneca Company Profile
5.4.2 Astrazeneca Business Overview
5.4.3 Astrazeneca Recurrent Glioblastoma Multiforme Treatment Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Astrazeneca Recurrent Glioblastoma Multiforme Treatment Products Introduction

6 Market Analysis and Forecast, By Product Types
6.1 Global Recurrent Glioblastoma Multiforme Treatment Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Recurrent Glioblastoma Multiforme Treatment Sales and Market Share by Types (2015-2020)
6.1.2 Global Recurrent Glioblastoma Multiforme Treatment Revenue and Market Share by Types (2015-2020)
6.1.3 Global Recurrent Glioblastoma Multiforme Treatment Price by Types (2015-2020)
6.2 Global Recurrent Glioblastoma Multiforme Treatment Market Forecast by Types (2020-2025)
6.2.1 Global Recurrent Glioblastoma Multiforme Treatment Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Recurrent Glioblastoma Multiforme Treatment Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Recurrent Glioblastoma Multiforme Treatment Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Recurrent Glioblastoma Multiforme Treatment Sales, Price and Growth Rate of AU-105
6.3.2 Global Recurrent Glioblastoma Multiforme Treatment Sales, Price and Growth Rate of Axitinib
6.3.3 Global Recurrent Glioblastoma Multiforme Treatment Sales, Price and Growth Rate of AXL-1717
6.3.4 Global Recurrent Glioblastoma Multiforme Treatment Sales, Price and Growth Rate of AZD-7451
6.3.5 Global Recurrent Glioblastoma Multiforme Treatment Sales, Price and Growth Rate of Others
6.4 Global Recurrent Glioblastoma Multiforme Treatment Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 AU-105 Market Revenue and Sales Forecast (2020-2025)
6.4.2 Axitinib Market Revenue and Sales Forecast (2020-2025)
6.4.3 AXL-1717 Market Revenue and Sales Forecast (2020-2025)
6.4.4 AZD-7451 Market Revenue and Sales Forecast (2020-2025)
6.4.5 Others Market Revenue and Sales Forecast (2020-2025)

7 Market Analysis and Forecast, By Applications
7.1 Global Recurrent Glioblastoma Multiforme Treatment Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Recurrent Glioblastoma Multiforme Treatment Sales and Market Share by Applications (2015-2020)
7.1.2 Global Recurrent Glioblastoma Multiforme Treatment Revenue and Market Share by Applications (2015-2020)
7.2 Global Recurrent Glioblastoma Multiforme Treatment Market Forecast by Applications (2020-2025)
7.2.1 Global Recurrent Glioblastoma Multiforme Treatment Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Recurrent Glioblastoma Multiforme Treatment Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Recurrent Glioblastoma Multiforme Treatment Revenue, Sales and Growth Rate of Hospital (2015-2020)
7.3.2 Global Recurrent Glioblastoma Multiforme Treatment Revenue, Sales and Growth Rate of Clinic (2015-2020)
7.3.3 Global Recurrent Glioblastoma Multiforme Treatment Revenue, Sales and Growth Rate of Others (2015-2020)
7.4 Global Recurrent Glioblastoma Multiforme Treatment Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Hospital Market Revenue and Sales Forecast (2020-2025)
7.4.2 Clinic Market Revenue and Sales Forecast (2020-2025)
7.4.3 Others Market Revenue and Sales Forecast (2020-2025)

8 Market Analysis and Forecast, By Regions
8.1 Global Recurrent Glioblastoma Multiforme Treatment Sales by Regions (2015-2020)
8.2 Global Recurrent Glioblastoma Multiforme Treatment Market Revenue by Regions (2015-2020)
8.3 Global Recurrent Glioblastoma Multiforme Treatment Market Forecast by Regions (2020-2025)

9 North America Recurrent Glioblastoma Multiforme Treatment Market Analysis
9.1 Market Overview and Prospect Analysis
9.2 North America Recurrent Glioblastoma Multiforme Treatment Market Sales and Growth Rate (2015-2020)
9.3 North America Recurrent Glioblastoma Multiforme Treatment Market Revenue and Growth Rate (2015-2020)
9.4 North America Recurrent Glioblastoma Multiforme Treatment Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Recurrent Glioblastoma Multiforme Treatment Market Analysis by Country
9.6.1 U.S. Recurrent Glioblastoma Multiforme Treatment Sales and Growth Rate
9.6.2 Canada Recurrent Glioblastoma Multiforme Treatment Sales and Growth Rate
9.6.3 Mexico Recurrent Glioblastoma Multiforme Treatment Sales and Growth Rate

10 Europe Recurrent Glioblastoma Multiforme Treatment Market Analysis
10.1 Market Overview and Prospect Analysis
10.2 Europe Recurrent Glioblastoma Multiforme Treatment Market Sales and Growth Rate (2015-2020)
10.3 Europe Recurrent Glioblastoma Multiforme Treatment Market Revenue and Growth Rate (2015-2020)
10.4 Europe Recurrent Glioblastoma Multiforme Treatment Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Recurrent Glioblastoma Multiforme Treatment Market Analysis by Country
10.6.1 Germany Recurrent Glioblastoma Multiforme Treatment Sales and Growth Rate
10.6.2 United Kingdom Recurrent Glioblastoma Multiforme Treatment Sales and Growth Rate
10.6.3 France Recurrent Glioblastoma Multiforme Treatment Sales and Growth Rate
10.6.4 Italy Recurrent Glioblastoma Multiforme Treatment Sales and Growth Rate
10.6.5 Spain Recurrent Glioblastoma Multiforme Treatment Sales and Growth Rate
10.6.6 Russia Recurrent Glioblastoma Multiforme Treatment Sales and Growth Rate

11 Asia-Pacific Recurrent Glioblastoma Multiforme Treatment Market Analysis
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Recurrent Glioblastoma Multiforme Treatment Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Recurrent Glioblastoma Multiforme Treatment Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Recurrent Glioblastoma Multiforme Treatment Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Recurrent Glioblastoma Multiforme Treatment Market Analysis by Country
11.6.1 China Recurrent Glioblastoma Multiforme Treatment Sales and Growth Rate
11.6.2 Japan Recurrent Glioblastoma Multiforme Treatment Sales and Growth Rate
11.6.3 South Korea Recurrent Glioblastoma Multiforme Treatment Sales and Growth Rate
11.6.4 Australia Recurrent Glioblastoma Multiforme Treatment Sales and Growth Rate
11.6.5 India Recurrent Glioblastoma Multiforme Treatment Sales and Growth Rate

12 South America Recurrent Glioblastoma Multiforme Treatment Market Analysis
12.1 Market Overview and Prospect Analysis
12.2 South America Recurrent Glioblastoma Multiforme Treatment Market Sales and Growth Rate (2015-2020)
12.3 South America Recurrent Glioblastoma Multiforme Treatment Market Revenue and Growth Rate (2015-2020)
12.4 South America Recurrent Glioblastoma Multiforme Treatment Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Recurrent Glioblastoma Multiforme Treatment Market Analysis by Country
12.6.1 Brazil Recurrent Glioblastoma Multiforme Treatment Sales and Growth Rate
12.6.2 Argentina Recurrent Glioblastoma Multiforme Treatment Sales and Growth Rate
12.6.3 Columbia Recurrent Glioblastoma Multiforme Treatment Sales and Growth Rate

13 Middle East and Africa Recurrent Glioblastoma Multiforme Treatment Market Analysis
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Recurrent Glioblastoma Multiforme Treatment Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Recurrent Glioblastoma Multiforme Treatment Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Recurrent Glioblastoma Multiforme Treatment Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Recurrent Glioblastoma Multiforme Treatment Market Analysis by Country
13.6.1 UAE Recurrent Glioblastoma Multiforme Treatment Sales and Growth Rate
13.6.2 Egypt Recurrent Glioblastoma Multiforme Treatment Sales and Growth Rate
13.6.3 South Africa Recurrent Glioblastoma Multiforme Treatment Sales and Growth Rate

14 Conclusions and Recommendations
14.1 Key Market Findings and Prospects
14.2 Advice for Investors

15 Appendix
15.1 Methodology
15.2 Research Data Source